  Cases of Middle<pathogen> East<pathogen> respiratory<disease> syndrome<disease> coronavirus<pathogen> ( MERS-CoV) continue to occur , making it one of the WHO 's targets for accelerated vaccine development. One vaccine candidate is based on live-attenuated measles<pathogen> virus<pathogen> ( MV<pathogen>) vaccine encoding the MERS-CoV spike glycoprotein ( MERS-S).